Prosurvival and antiapoptotic effects of PGE2 in radiation injury are mediated by EP2 receptor in intestine

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 284, Issue 3 47-3, 2003, Pages

  Houchen, Courtney W ^a,c   Sturmoski, Mark A ^a   Anant, Shrikant ^a   Breyer, Richard M ^b   Stenson, William F ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Division of Gastroenterology   (United States)

Author keywords

Cyclooxygenase; Prostaglandin; Prostaglandins; Receptor signaling

Indexed keywords

G PROTEIN COUPLED RECEPTOR; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E2; PROSTAGLANDIN EP1 RECEPTOR; PROSTAGLANDIN EP2 RECEPTOR; PROSTAGLANDIN EP3 RECEPTOR; PROSTAGLANDIN EP4 RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL SURVIVAL; GAMMA IRRADIATION; INTESTINE CRYPT; INTESTINE EPITHELIUM CELL; INTESTINE INJURY; LIGAND BINDING; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIATION INJURY; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; STEM CELL;

EID: 0037370897     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.00240.2002     Document Type: Article

References (55)

1. Abramovitz M, Adam M, Boie Y, Carriere M, Denis D, Godbout C, Lamontagne S, Rochette C, Sawyer N, Tremblay NM, Belley M, Gallant M, Dufresne C, Gareau Y, Ruel R, Juteau H, Labelle M, Ouimet N, and Metters KM. The utilization of recombinant prostanoid receptors to determine the affinities and selectivities of prostaglandins and related analogs. Biochim Biophys Acta 1483: 285-293, 2000.
2. Argenzio RA, Henrikson CK, and Liacos JA. Effect of prostaglandin inhibitors on bile salt-induced mucosal damage of porcine colon. Gastroenterology 96: 95-109, 1989.
3. Bamba H, Ota S, Kato A, Kawamoto C, and Fujiwara K. Prostaglandins up-regulate vascular endothelial growth factor production through distinct pathways in differentiated U937 cells. Biochem Biophys Res Commun 273: 485-491, 2000.
4. Bhattacharya M, Peri KG, Almazan G, Ribeiro-da-Silva A, Shichi H, Durocher Y, Abramovitz M, Hou X, Varma DR, and Chemtob S. Nuclear localization of prostaglandin E2 receptors. Proc Natl Acad Sci USA 95: 15792-15797, 1998.
5. Breyer RM, Emeson RB, Tarng JL, Breyer MD, Davis LS, Abromson RM, and Ferrenbach SM. Alternative splicing generates multiple isoforms of a rabbit prostaglandin E2 receptor. J Biol Chem 269: 6163-6169, 1994.
6. Cai WB, Roberts SA, Bowley E, Hendry JH, and Potten CS. Differential survival of murine small and large intestinal crypts following ionizing radiation. Int J Radiat Biol 71: 145-155, 1997.
7. Chulada PC, Thompson MB, Mahler JF, Doyle CM, Gaul BW, Lee C, Tiano HF, Morham SG, Smithies O, and Langenbach R. Genetic disruption of Ptgs-1, as well as Ptgs-2, reduces intestinal tumorigenesis in Min mice. Cancer Res 60: 4705-4708, 2000.
8. Coffey RJ, Hawkey CJ, Damstrup L, Graves-Deal R, Daniel VC, Dempsey PJ, Chinery R, Kirkland SC, DuBois RN, Jetton TL, and Morrow JD. Epidermal growth factor receptor activation induces nuclear targeting of cyclooxygenase-2, basolateral release of prostaglandins, and mitogenesis in polarizing colon cancer cells. Proc Natl Acad Sci USA 94: 657-662, 1997.
9. Cohn SM and Lieberman MW. The use of antibodies to 5-bromo-2′-deoxyuridine for the isolation of DNA sequences containing excision-repair sites. J Biol Chem 259: 12456-12462, 1984.
10. Cohn SM, Schloemann S, Tessner T, Seibert K, and Stenson WF. Crypt stem cell survival in the mouse intestinal epithelium is regulated by prostaglandins synthesized through cyclooxygenase-1. J Clin Invest 99: 1367-1379, 1997.
11. Cohn SM, Simon TC, Roth KA, Birkenmeier EH, and Gordon JI. Use of transgenic mice to map cis-acting elements in the intestinal fatty acid binding protein gene (Fabpi) that control its cell lineage-specific and regional patterns of expression along the duodenal-colonic and crypt-villus axes of the gut epithelium. J Cell Biol 119: 27-44, 1992.
12. Coleman RA, Smith WL, and Narumiya S. International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes. Pharmacol Rev 46: 205-229, 1994.
13. Ding M, Kinoshita Y, Kishi K, Nakata H, Hassan S, Kawanami C, Sugimoto Y, Katsuyama M, Negishi M, Narumiya S, Ichikawa A, and Chiba T. Distribution of prostaglandin E receptors in the rat gastrointestinal tract. Prostaglandins 53: 199-216, 1997.
14. DuBois RN, Radhika A, Reddy BS, and Entingh AJ. Increased cyclooxygenase-2 levels in carcinogen-induced rat colonic tumors. Gastroenterology 110: 1259-1262., 1996.
15. Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S, and DuBois RN. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 107: 1183-1188, 1994.
16. Eberhart CE and Dubois RN. Eicosanoids and the gastrointestinal tract. Gastroenterology 109: 285-301, 1995.
17. Hallahan DE, Dunphy E, Virudachalam S, Sukhatme VP, Kufe DW, and Weichselbaum RR. C-jun and Egr-1 participate in DNA synthesis and cell survival in response to ionizing radiation exposure. J Biol Chem 270: 30303-30309, 1995.
18. Hawkey CJ and Rampton DS. Prostaglandins and the gastrointestinal mucosa: are they important in its function, disease, or treatment? Gastroenterology 89: 1162-1188, 1985.
19. Herschman HR. Regulation of prostaglandin synthase-1 and prostaglandin synthase-2. Cancer Metastasis Rev 13: 241-256, 1994.
20. Houchen CW, Stenson WF, and Cohn SM. Disruption of cyclooxygenase-1 gene results in an impaired response to radiation injury. Am J Physiol Gastrointest Liver Physiol 279: G858-G865, 2000.
21. Jumblatt MM. Autocrine regulation of corneal endothelium by prostaglandin E2. Invest Ophthalmol Vis Sci 35: 2783-2790, 1994.
22. Jumblatt MM. PGE2 synthesis and response pathways in cultured corneal endothelial cells: the effects of in vitro aging. Curr Eye Res 16: 428-435, 1997.
23. Kanai N, Lu R, Satriano JA, Bao Y, Wolkoff AW, and Schuster VL. Identification and characterization of a prostaglandin transporter. Science 268: 866-869, 1995.
24. 2 receptor. Nat Med 5: 217-220, 1999.
25. Legrand-Poels S, Schoonbroodt S, Matroule JY, and Piette J. Nf-κB: an important transcription factor in photobiology. J Photochem Photobiol B 45: 1-8, 1998.
26. 2 receptor impairs osteoclastogenesis in vitro. Endocrinology 141: 2054-2061, 2000.
27. Lim CP, Jain N, and Cao X. Stress-induced immediate-early gene, egr-1, involves activation of p38/JNK1. Oncogene 16: 2915-2926, 1998.
28. Longo WE, Grossmann EM, Erickson B, Panesar N, Mazuski JE, and Kaminski DL. The effect of phospholipase A2 inhibitors on proliferation and apoptosis of murine intestinal cells. J Surg Res 84: 51-56, 1999.
29. Lu R, Kanai N, Bao Y, and Schuster VL. Cloning, in vitro expression, and tissue distribution of a human prostaglandin transporter cDNA(hPGT). J Clin Invest 98: 1142-1149, 1996.
30. 4 in human kidney. J Am Soc Nephrol 10: 1851-1860, 1999.
31. Morimoto K, Sugimoto Y, Katsuyama M, Oida H, Tsuboi K, Kishi K, Kinoshita Y, Negishi M, Chiba T, Narumiya S, and Ichikawa A. Cellular localization of mRNAs for prostaglandin E receptor subtypes in mouse gastrointestinal tract. Am J Physiol Gastrointest Liver Physiol 272: G681-G687, 1997.
32. Narumiya S. Molecular diversity of prostanoid receptors; subtypes and soforms of prostaglandin E receptor. Adv Exp Med Biol: 207-213, 1997.
33. Narumiya S, Sugimoto Y, and Ushikubi F. Prostanoid receptors: structures, properties, and functions. Physiol Rev 79: 1193-1226, 1999.
34. Oshima M, Dinchuk JE, Kargman SL, Oshima H, Hancock B, Kwong E, Trzaskos JM, Evans JF, and Taketo MM. Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 87: 803-809, 1996.
35. Paris F, Fuks Z, Kang A, Capodieci P, Juan G, Ehleiter D, Haimovitz-Friedman A, Cordon-Cardo C, and Kolesnick R. Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice. Science 293: 293-297, 2001.
36. Pierce KL, Gil DW, Woodward DF, and Regan JW. Cloning of human prostanoid receptors. Trends Pharmacol Sci 16: 253-256, 1995.
37. Potten CS and Booth C. The role of radiation-induced and spontaneous apoptosis in the homeostasis of the gastrointestinal epithelium: a brief review. Comp Biochem Physiol B Biochem Mol Biol 118: 473-478, 1997.
38. Potten CS, Booth D, and Haley JD. Pretreatment with transforming growth factor β-3 protects small intestinal stem cells against radiation damage in vivo. Br J Cancer 75: 1454-1459, 1997.
39. Potten CS and Grant HK. The relationship between ionizing radiation-induced apoptosis and stem cells in the small and large intestine. Br J Cancer 78: 993-1003, 1998.
40. Potten CS and Loeffler M. Stem cells: attributes, cycles, spirals, pitfalls and uncertainties. Lessons for and from the crypt Development 110: 1001-1020, 1990.
41. Potten CS, Rezvani M, Hendry JH, Moore JV, and Major D. The correction of intestinal microcolony counts for variation in size. Int J Radiat Biol 40: 321-326, 1981.
42. 2. Gut 35: 675-678, 1994.
43. Riehl T, Cohn S, Tessner T, Schloemann S, and Stenson WF. Lipopolysaccharide is radioprotective in the mouse intestine through a prostaglandin-mediated mechanism. Gastroenterology 118: 1106-1116, 2000.
44. Roberts SA and Potten CS. Clonogen content of intestinal crypts: its deduction using a microcolony assay on whole mount preparations and its dependence on radiation dose. Int J Radiat Biol 65: 477-481, 1994.
45. Schievella AR, Regier MK, Smith WL, and Lin LL. Calcium-mediated translocation of cytosolic phospholipase A2 to the nuclear envelope and endoplasmic reticulum. J Biol Chem 270: 30749-30754, 1995.
46. Seibert K, Masferrer J, Zhang Y, Gregory S, Olson G, Hauser S, Leahy K, Perkins W, and Isakson P. Mediation of inflammation by cyclooxygenase-2. Agents Actions Suppl 46: 41-50, 1995.
47. Shao J, Sheng H, Inoue H, Morrow JD, and DuBois RN. Regulation of constitutive cyclooxygenase-2 expression in colon carcinoma cells. J Biol Chem 275: 33951-33956, 2000.
48. Shattuck-Brandt RL, Varilek GW, Radhika A, Yang F, Washington MK, and DuBois RN. Cyclooxygenase 2 expression is increased in the stroma of colon carcinomas from IL-10(-/-) mice. Gastroenterology 118: 337-345, 2000.
49. 2 increases growth and motility of colorectal carcinoma cells. J Biol Chem 276: 18075-18081, 2001.
50. Singer II, Kawka DW, Schloemann S, Tessner T, Riehl T, and Stenson WF. Cyclooxygenase 2 is induced in colonic epithelial cells in inflammatory bowel disease. Gastroenterology 115: 297-306, 1998.
51. 2 in Apc-(Delta 716) knockout mice. Nat Med 7: 1048-1051, 2001.
52. Spencer AG, Woods JW, Arakawa T, Singer, II, and Smith WL. Subcellular localization of prostaglandin endoperoxide H synthases-1 and -2 by immunoelectron microscopy. J Biol Chem 273: 9886-9893, 1998.
53. Takeuchi K, Ukawa H, Furukawa O, Kawauchi S, Araki H, Sugimoto Y, Ishikawa A, Ushikubi F, and Narumiya S. Prostaglandin E receptor subtypes involved in stimulation of gastroduodenal bicarbonate secretion in rats and mice. J Physiol Pharmacol 50: 155-167, 1999.
54. Williams C, Shattuck-Brandt RL, and DuBois RN. The role of COX-2 in intestinal cancer. Ann NY Acad Sci 889: 72-83, 1999.
55. Zhang W and Chen S. EGR-1, a UV-inducible gene in p53(-/-) mouse cells. Exp Cell Res 266: 21-30, 2001.